4Indexed trials
biological · Product Intelligence
Favezelimab/Pembrolizumab
Pipeline Intelligence
Favezelimab/Pembrolizumab: 4 indexed trials, 1 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
1Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT04305054Merck Sharp & Dohme LLC · parkinsonsPHASE1,PHASE2
NCT05064059Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT05508867Merck Sharp & Dohme LLC · parkinsonsPHASE2
NCT06036836Merck Sharp & Dohme LLC · parkinsonsPHASE2
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.